Litigation Details for Amicus Therapeutics US, LLC v. Teva Pharmaceutical Industries Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Amicus Therapeutics US, LLC v. Teva Pharmaceutical Industries Ltd. (D. Del. 2022)
| Docket | ⤷ Sign Up | Date Filed | 2022-11-07 |
| Court | District Court, D. Delaware | Date Terminated | 2024-10-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Christopher J. Burke |
| Jury Demand | None | Referred To | |
| Patents | 10,076,514; 10,251,873; 10,383,864; 10,406,143; 10,471,053; 10,525,045; 8,592,362; 9,000,011; 9,095,584; 9,480,682; 9,987,263; 9,999,618 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Amicus Therapeutics US, LLC v. Teva Pharmaceutical Industries Ltd.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Amicus Therapeutics US, LLC v. Teva Pharmaceutical Industries Ltd. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2022-11-07 | 1 | Complaint | U.S. Patent Nos. 8,592,362; 9,000,011; 9,095,584; 9,480,682; 9,987,263; 9,999,618; 10,076,514; 10,251,873…civil action for patent infringement of U.S. Patent Nos. 10,792,279 (the “ʼ279 Patent”), 10,806,727 (the…(the “ʼ727 Patent”), 10,849,889 (the “ʼ889 Patent”), 10,849,890 (the “ʼ890 Patent”), 10,874,655 (the …the “ʼ655 Patent”), 11,278,536 (the “ʼ536 Patent”), 11,278,537 (the “ʼ537 Patent”), 11,278,538 (the “ʼ538…ʼ538 Patent”), 11,278,539 (the “ʼ539 Patent”), 11,278,540 (the “ʼ540 Patent”), 11,357,761 (the “ʼ761 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
